Tong Sun, MD, PhD
Assistant Professor of Pathology
Research & Publications
Biography
News
Coauthors
Selected Publications
- Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinomaSun T, Gilani S, Jain D, Cai G. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma. Diagnostic Cytopathology 2023, 51: 674-683. PMID: 37469257, DOI: 10.1002/dc.25196.
- Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy riskWang M, Sun T, Jiao J, Wang H. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk. Cancer Cytopathology 2023, 131: 433-441. PMID: 36973963, DOI: 10.1002/cncy.22696.
- KRAS mutational analysis: a new supplementary diagnostic tool for extrahepatic biliary stenosisSun T. KRAS mutational analysis: a new supplementary diagnostic tool for extrahepatic biliary stenosis. Future Oncology 2023, 19: 5-6. PMID: 36651534, DOI: 10.2217/fon-2022-0937.
- Cytological Evaluation of Upper Urinary Tract Specimens: An Institutional Retrospective Study Using The Paris System for Reporting Urine Cytology Second Edition with Histopathologic Follow UpKhajir G, Sun T, Wang H, Adeniran A, Cai G, Levi A. Cytological Evaluation of Upper Urinary Tract Specimens: An Institutional Retrospective Study Using The Paris System for Reporting Urine Cytology Second Edition with Histopathologic Follow Up. Journal Of The American Society Of Cytopathology 2022, 11: s35. DOI: 10.1016/j.jasc.2022.07.065.
- Fine-Needle Aspiration Evaluation of Pancreatic Cysts: An Institutional Experience Using the Upcoming WHO International System for Reporting Pancreaticobiliary CytopathologySardana R, Wang M, Gilani S, Sun T, Cai G. Fine-Needle Aspiration Evaluation of Pancreatic Cysts: An Institutional Experience Using the Upcoming WHO International System for Reporting Pancreaticobiliary Cytopathology. Journal Of The American Society Of Cytopathology 2022, 11: s62. DOI: 10.1016/j.jasc.2022.07.113.
- Cervical Cancer Screening Using Primary High-Risk HPV (hrHPV) Versus Cotesting: Implications for hrHPV-Negative Patients with High Grade Squamous Epithelial LesionManrai P, Levi A, Sun T, Wang M, Cai G, Abi-Raad R. Cervical Cancer Screening Using Primary High-Risk HPV (hrHPV) Versus Cotesting: Implications for hrHPV-Negative Patients with High Grade Squamous Epithelial Lesion. Journal Of The American Society Of Cytopathology 2022, 11: s32. DOI: 10.1016/j.jasc.2022.07.060.
- Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studiesSun T, Wang M, Wang H. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies. Cancer Cytopathology 2022, 130: 964-973. PMID: 35994357, DOI: 10.1002/cncy.22638.
- Further Characterization of Clinicopathologic Features of Cystic Neutrophilic Granulomatous MastitisLiang Y, Zhan H, Krishnamurti U, Harigopal M, Sun T. Further Characterization of Clinicopathologic Features of Cystic Neutrophilic Granulomatous Mastitis. American Journal Of Clinical Pathology 2022, 158: 488-493. PMID: 35899981, DOI: 10.1093/ajcp/aqac074.
- Cytomorphologic features of SMARCA4‐deficient non–small cell lung carcinoma and correlation with immunohistochemical and molecular featuresSun T, Gilani SM, Podany P, Harigopal M, Zhong M, Wang H. Cytomorphologic features of SMARCA4‐deficient non–small cell lung carcinoma and correlation with immunohistochemical and molecular features. Cancer Cytopathology 2022, 130: 620-629. PMID: 35468657, DOI: 10.1002/cncy.22581.
- Significance of KRAS mutation testing in biliary brushing cytology specimens: A 10‐year retrospective reviewSun T, Zuo T, Hui P, Cai G. Significance of KRAS mutation testing in biliary brushing cytology specimens: A 10‐year retrospective review. Cancer Cytopathology 2022, 130: 558-565. PMID: 35417072, DOI: 10.1002/cncy.22579.
- Somatic Mutation of BAP1 Can Lead to Expression Loss in Non-Small Cell Lung Carcinoma: Next Generation Sequencing and IHC Analysis in A Large Single Institute CohortSun T, Wang X, Wang M, Minerowicz C, Sanchez H, Laskin W, Cohen P, Zhong M. Somatic Mutation of BAP1 Can Lead to Expression Loss in Non-Small Cell Lung Carcinoma: Next Generation Sequencing and IHC Analysis in A Large Single Institute Cohort. International Journal Of Surgical Pathology 2021, 30: 512-519. PMID: 34970936, DOI: 10.1177/10668969211070179.
- Diagnostic value of a comprehensive, urothelial carcinoma–specific next‐generation sequencing panel in urine cytology and bladder tumor specimensSun T, Hutchinson L, Tomaszewicz K, Caporelli M, Meng X, McCauley K, Fischer AH, Cosar EF, Cornejo KM. Diagnostic value of a comprehensive, urothelial carcinoma–specific next‐generation sequencing panel in urine cytology and bladder tumor specimens. Cancer Cytopathology 2021, 129: 537-547. PMID: 33539671, DOI: 10.1002/cncy.22410.
- Crystalloids in FNA specimens of salivary gland lesions: A retrospective study in a single large instituteSun T, Faquin WC, Torous VF. Crystalloids in FNA specimens of salivary gland lesions: A retrospective study in a single large institute. Cancer Cytopathology 2020, 129: 432-438. PMID: 33296146, DOI: 10.1002/cncy.22395.
- Determining the significance of psammoma bodies in pelvic washings: A 10‐year retrospective reviewSun T, Pitman MB, Torous VF. Determining the significance of psammoma bodies in pelvic washings: A 10‐year retrospective review. Cancer Cytopathology 2020, 129: 83-89. PMID: 32931128, DOI: 10.1002/cncy.22346.
- The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC)Sun T, Akalin A, Dresser K, Fischer AH, Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC). Head And Neck Pathology 2020, 15: 389-394. PMID: 32661670, PMCID: PMC8134651, DOI: 10.1007/s12105-020-01202-7.
- Oil red O staining for lipid-laden macrophage index of bronchoalveolar lavage: interobserver agreement and challenges to interpretationTorous VF, Brackett D, Brown P, Edwin N, Heidarian A, Lobuono C, Sun T, Pitman MB, Ly A. Oil red O staining for lipid-laden macrophage index of bronchoalveolar lavage: interobserver agreement and challenges to interpretation. Journal Of The American Society Of Cytopathology 2020, 9: 563-569. PMID: 32674937, DOI: 10.1016/j.jasc.2020.05.010.
- The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal OncocytomaSun T, Hutchinson L, Zhou AG, Liu Q, Cosar EF, St. Cyr M, Ninteau N, Dresser K, Cheng L, Jiang Z, Cornejo KM. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma. International Journal Of Surgical Pathology 2019, 28: 259-264. PMID: 31640438, DOI: 10.1177/1066896919883016.
- The Utility of MYB Immunohistochemistry (IHC) in Cytology Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (ACC)Sun T, Akalin A, Dresser K, Fischer A, Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Cytology Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (ACC). Journal Of The American Society Of Cytopathology 2019, 8: s37-s38. DOI: 10.1016/j.jasc.2019.08.088.
- The Role of a Comprehensive Urothelial Carcinoma Specific Next Generation Sequencing Panel in the Cytologic Diagnosis of Urothelium CarcinomaSun T, Hutchinson L, Tomaszewicz K, Caporelli M, Meng X, Cosar E, Fischer A, Cornejo K. The Role of a Comprehensive Urothelial Carcinoma Specific Next Generation Sequencing Panel in the Cytologic Diagnosis of Urothelium Carcinoma. Journal Of The American Society Of Cytopathology 2018, 7: s46-s47. DOI: 10.1016/j.jasc.2018.06.109.
- Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.Xie W, Yang M, Chan J, Sun T, Mucci LA, Penney KL, Lee GS, Kantoff PW. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis. The Prostate 2016, 76: 691-9. PMID: 26847995, PMCID: PMC5510241, DOI: 10.1002/pros.23160.
- Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancerDu Z, Sun T, Hacisuleyman E, Fei T, Wang X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW, Liu XS. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nature Communications 2016, 7: 10982. PMID: 26975529, PMCID: PMC4796315, DOI: 10.1038/ncomms10982.
- The role of miRNAs in prostate cancer.Sun T, McKay R, Lee GS, Kantoff P. The role of miRNAs in prostate cancer. European Urology 2015, 68: 589-90. PMID: 25577717, DOI: 10.1016/j.eururo.2014.12.037.
- Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer.Huang YQ, Sun T, Zhong WD, Wu CL. Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer. American Journal Of Clinical And Experimental Urology 2014, 2: 343-50. PMID: 25606581, PMCID: PMC4297331.
- Emerging players in prostate cancer: long non-coding RNAs.Sun T, Ye H, Wu CL, Lee GS, Kantoff PW. Emerging players in prostate cancer: long non-coding RNAs. American Journal Of Clinical And Experimental Urology 2014, 2: 294-9. PMID: 25606575, PMCID: PMC4297325.
- The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer.Sun T, Yang M, Chen S, Balk S, Pomerantz M, Hsieh CL, Brown M, Lee GM, Kantoff PW. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer. The Prostate 2012, 72: 1093-103. PMID: 22127852, PMCID: PMC3810996, DOI: 10.1002/pros.22456.
- Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort.Sun T, Mary LG, Oh WK, Freedman ML, Pomerantz M, Pienta KJ, Kantoff PW. Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2011, 17: 1546-52. PMID: 21135144, PMCID: PMC3060307, DOI: 10.1158/1078-0432.CCR-10-2015.
- Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.Sun T, Lee GS, Oh WK, Pomerantz M, Yang M, Xie W, Freedman ML, Kantoff PW. Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2010, 16: 5244-51. PMID: 20855462, PMCID: PMC2970725, DOI: 10.1158/1078-0432.CCR-10-1261.
- Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.Sun T, Lee GS, Werner L, Pomerantz M, Oh WK, Kantoff PW, Freedman ML. Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy. Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology 2010, 19: 1871-8. PMID: 20615892, PMCID: PMC3755451, DOI: 10.1158/1055-9965.EPI-10-0216.
- The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Research 2009, 69: 3356-63. PMID: 19351832, PMCID: PMC2703812, DOI: 10.1158/0008-5472.CAN-08-4112.